The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“altered phosphorylation has been correlated with both increases ( Lucas et al. 2001) and decreases ( Spittaels et al. 2000) in neurodegeneration.”
From Genetic modifiers of tauopathy in Drosophila (2003) · cites this paper as Lucas et al. 2001
In the citing paper
“Overexpression of GSK3 𝛃 in mice induces Tau hyperphosphorylation”
From Genetic modifiers of tauopathy in Drosophila (2003) · cites this paper as Lucas et al. 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“Regulation of the system is achieved through the tetracycline-regulated transactivator (tTA), a chimeric protein comprised of the tet-repressor DNA-binding domain and the transactivation domain of viral protein VP16 of herpes simplex virus (Gossen and Bujard, 1992).”
BackgroundAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Control of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550 · cited 2×
“In the tTA mouse lines, the tTA transgene is under the control of the calcium/calmodulin kinase IIa promoter (CamKIIa±tTA lines E and B) (Mayford et al., 1996).”
BackgroundNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 1×
“NFTs are intraneuronally generated aggregates of paired helical ®laments (PHFs), which are assembled from hyperphosphorylated forms of the microtubule-associated protein tau (Grundke-Iqbal et al., 1986; Lee et al., 1991).”
BackgroundRequirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067
Self-citationRole of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Normal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Braak, F., Braak, H., & Mandelkow, E. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 772
über eigenartige Krankheitsfälle des späteren Alters
Alzheimer, A. (1911) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02866241 · Cited by 710
Axonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling
Hall, A. C., Lucas, F. R., & Salinas, P. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80689-3 · Cited by 686
Signal transduction through beta-catenin and specification of cell fate during embryogenesis.
Miller, J. R., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.20.2527 · Cited by 656
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 572
Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564
Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways
Barth, A. I., Näthke, I. S., & Nelson, W. J. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80122-6 · Cited by 537
Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520 · cited 1×
“Alternatively, it may simply not be possible to mimic all aspects of AD neuropathology in mice because it requires human-speci®c clues [as is the case for b-amyloid induced toxicity in vivo (Geula et al., 1998)].”
BackgroundDestabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
Zhang, Z., Hartmann, H., Minh Do, V., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., et al. (1998) · Nature · doi:10.1038/27208 · Cited by 517
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469
Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00011 · Cited by 459
Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal
Hetman, M., Cavanaugh, J. E., Kimelman, D., & Xia, Z. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02567.2000 · Cited by 440
Götz, J., Probst, A., Spillantini, M. G., Schäfer, T., Jakes, R., Bürki, K., & Goedert, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07116.x · Cited by 439
Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., & Imahori, K. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81066-9 · Cited by 402
Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommel, A., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65533-2 · Cited by 385
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 381
Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D.-M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16470 · Cited by 367
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
Manji, H. K., Moore, G. J., & Chen, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00165-1 · Cited by 313
Co-regulation of two gene activities by tetracycline via a bidirectional promoter
Baron, U., Freundlieb, S., Gossen, M., & Bujard, H. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.17.3605 · Cited by 312
WNT-7a Induces Axonal Remodeling and Increases Synapsin I Levels in Cerebellar Neurons
Lucas, F. R., & Salinas, P. C. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8734 · Cited by 274
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260 · cited 1×
“Exposure of cortical and hippocampal primary neuronal cultures to Ab has been shown to induce activation of GSK-3b (Takashima et al., 1996), tau hyperphosphoryl- Decreased nuclear b-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3b conditional transgenic mice ã European Molecular…”
BackgroundEger, A., Stockinger, A., Schaffhauser, B., Beug, H., & Foisner, R. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.1.173 · Cited by 205
Lovestone, S., Hartley, C. L., Pearce, J., & Anderton, B. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00126-1 · Cited by 201
Brion, J.-P., Tremp, G., & Octave, J.-N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65272-8 · Cited by 197
Ferreira, A., Lu, Q., Orecchio, L., & Kosik, K. S. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0615 · Cited by 178
Direct association of presenilin‐1 with β‐catenin
Murayama, M., Tanaka, S., Palacino, J. J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B. L., & Takashima, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00886-2 · Cited by 176
ALZHEIMER'S DISEASE: PAIRED HELICAL FILAMENTS AND CYTOMEMBRANES
GRAY, E. G., PAULA‐BARBOSA, M., & ROHER, A. (1987) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1987.tb00174.x · Cited by 160
Mutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB
Weihl, C. C., Ghadge, G. D., Kennedy, S. G., Hay, N., Miller, R. J., & Roos, R. P. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05360.1999 · Cited by 147
Tau protein I is essential for amyloid β-protein iduced neurotoxicity
Takashima, A. (1993) · Medical Entomology and Zoology · Cited by 125
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
Brownlees, J., Irving, N. G., Brion, J., Gibb, B. J. M., Wagner, U., Woodgett, J. R., & Miller, C. C. J. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00013 · Cited by 99
INDUCIBLE GENE EXPRESSION IN THE NERVOUS SYSTEM OF TRANSGENIC MICE
Gingrich, J. R., & Roder, J. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.377 · Cited by 87
New Insights into the Genetics of Alzheimer's Disease
Hardy, J. (1996) · Annals of Medicine · doi:10.3109/07853899609033127 · Cited by 80
Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology
Shiurba, R., Ishiguro, K., Takahashi, M., Sato, K., Spooner, E. T., Mercken, M. H., Yoshida, R. Y., Wheelock, T. R., Yanagawa, H., Imahori, K., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00717-2 · Cited by 74
Progress toward valid transgenic mouse models for Alzheimer’s disease
Guénette, S. Y., & Tanzi, R. E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00042-1 · Cited by 73
Papasozomenos, S. C. (1989) · PubMed · Cited by 70
The cytoskeleton in Alzheimer disease
Terry, R. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_12 · Cited by 70
Alzheimer's disease: Clues from flies and worms
Anderton, B. H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80062-1 · Cited by 54
Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study
Nelson, P. T., Marton, L. S., & Saper, C. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)91385-6 · Cited by 33
Neuronal transformations in Alzheimer's disease
Metuzals, J., Robitaille, Y., Houghton, S., Gauthier, S. G., Kang, C. Y., & Leblanc, R. (1988) · Cell and Tissue Research · doi:10.1007/bf00214366 · Cited by 22
Cited by
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
The GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005
Self-citationGSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 808
Metadata
- Authors
- Lucas, J. J.
- Venue
- The EMBO Journal
- Published
- 2001-01-15
- Volume
- 20
- Issue
- 1
- Pages
- 27-39
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2114358785
- Cited by
- 900
- References
- 61
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.